Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 198


Targeting the untargetable? Nodal expression in TNBC.

Young ED, Welch DR.

Cell Cycle. 2016 Mar 30:1. [Epub ahead of print] No abstract available.


Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome-wide shRNA screen.

Kurahara H, Bohl C, Natsugoe S, Nishizono Y, Harihar S, Sharma R, Iwakuma T, Welch DR.

Int J Cancer. 2016 Mar 25. doi: 10.1002/ijc.30110. [Epub ahead of print]


Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration.

Roesley SN, Suryadinata R, Morrish E, Tan AR, Issa SM, Oakhill JS, Bernard O, Welch DR, Šarčević B.

Cell Cycle. 2016 Jan 2;15(1):137-51. doi: 10.1080/15384101.2015.1121328.


In vitro biophysical, microspectroscopic and cytotoxic evaluation of metastatic and non-metastatic cancer cells in responses to anti-cancer drug.

Li Q, Xiao L, Harihar S, Welch DR, Vargis E, Zhou A.

Anal Methods. 2015 Dec 21;7(24):10162-10169. Epub 2015 Nov 3.


Tumor Heterogeneity--A 'Contemporary Concept' Founded on Historical Insights and Predictions.

Welch DR.

Cancer Res. 2016 Jan 1;76(1):4-6. doi: 10.1158/0008-5472.CAN-15-3024. Epub 2016 Jan 3.


Essential Components of Cancer Education.

Welch DR, Antalis TM, Burnstein K, Vona-Davis L, Jensen RA, Nakshatri H, Riegel AT, Spitz DR, Watson DK, Weiner GJ; Cancer Biology Training Consortium.

Cancer Res. 2015 Dec 15;75(24):5202-5. doi: 10.1158/0008-5472.CAN-15-2077. Epub 2015 Dec 1. Review.


Mitochondrial Genetics Regulate Breast Cancer Tumorigenicity and Metastatic Potential.

Feeley KP, Bray AW, Westbrook DG, Johnson LW, Kesterson RA, Ballinger SW, Welch DR.

Cancer Res. 2015 Oct 15;75(20):4429-36. doi: 10.1158/0008-5472.CAN-15-0074.


Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells.

Rangarajan P, Subramaniam D, Paul S, Kwatra D, Palaniyandi K, Islam S, Harihar S, Ramalingam S, Gutheil W, Putty S, Pradhan R, Padhye S, Welch DR, Anant S, Dhar A.

Oncotarget. 2015 Sep 29;6(29):27661-73. doi: 10.18632/oncotarget.4871.


MTBP inhibits migration and metastasis of hepatocellular carcinoma.

Bi Q, Ranjan A, Fan R, Agarwal N, Welch DR, Weinman SA, Ding J, Iwakuma T.

Clin Exp Metastasis. 2015 Apr;32(4):301-11. doi: 10.1007/s10585-015-9706-5. Epub 2015 Mar 11.


Imaging of epidermal growth factor receptor on single breast cancer cells using surface-enhanced Raman spectroscopy.

Xiao L, Harihar S, Welch DR, Zhou A.

Anal Chim Acta. 2014 Sep 16;843:73-82. doi: 10.1016/j.aca.2014.06.036. Epub 2014 Jun 21.


Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.

Liu W, Vivian CJ, Brinker AE, Hampton KR, Lianidou E, Welch DR.

Cancer Microenviron. 2014 Dec;7(3):117-31. doi: 10.1007/s12307-014-0148-4. Epub 2014 Jun 18.


Toward a drug development path that targets metastatic progression in osteosarcoma.

Khanna C, Fan TM, Gorlick R, Helman LJ, Kleinerman ES, Adamson PC, Houghton PJ, Tap WD, Welch DR, Steeg PS, Merlino G, Sorensen PH, Meltzer P, Kirsch DG, Janeway KA, Weigel B, Randall L, Withrow SJ, Paoloni M, Kaplan R, Teicher BA, Seibel NL, Smith M, Uren A, Patel SR, Trent J, Savage SA, Mirabello L, Reinke D, Barkaukas DA, Krailo M, Bernstein M.

Clin Cancer Res. 2014 Aug 15;20(16):4200-9. doi: 10.1158/1078-0432.CCR-13-2574. Epub 2014 May 6.


Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer.

Balgkouranidou I, Chimonidou M, Milaki G, Tsarouxa EG, Kakolyris S, Welch DR, Georgoulias V, Lianidou ES.

Br J Cancer. 2014 Apr 15;110(8):2054-62. doi: 10.1038/bjc.2014.104. Epub 2014 Mar 18.


Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas.

Jones J, Wang H, Karanam B, Theodore S, Dean-Colomb W, Welch DR, Grizzle W, Yates C.

Clin Exp Metastasis. 2014 Jun;31(5):497-510. doi: 10.1007/s10585-014-9644-7. Epub 2014 Feb 26.


Furin is the major proprotein convertase required for KISS1-to-Kisspeptin processing.

Harihar S, Pounds KM, Iwakuma T, Seidah NG, Welch DR.

PLoS One. 2014 Jan 13;9(1):e84958. doi: 10.1371/journal.pone.0084958. eCollection 2014.


Metastasis suppressor KISS1 seems to reverse the Warburg effect by enhancing mitochondrial biogenesis.

Liu W, Beck BH, Vaidya KS, Nash KT, Feeley KP, Ballinger SW, Pounds KM, Denning WL, Diers AR, Landar A, Dhar A, Iwakuma T, Welch DR.

Cancer Res. 2014 Feb 1;74(3):954-63. doi: 10.1158/0008-5472.CAN-13-1183. Epub 2013 Dec 18.


Metastasis suppressors in breast cancers: mechanistic insights and clinical potential.

Bohl CR, Harihar S, Denning WL, Sharma R, Welch DR.

J Mol Med (Berl). 2014 Jan;92(1):13-30. doi: 10.1007/s00109-013-1109-y. Epub 2013 Dec 6. Review.


MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro.

Moon HJ, Finney J, Xu L, Moore D, Welch DR, Mure M.

J Biol Chem. 2013 Oct 18;288(42):30000-8. doi: 10.1074/jbc.C113.502310. Epub 2013 Sep 6.


Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix.

Khotskaya YB, Beck BH, Hurst DR, Han Z, Xia W, Hung MC, Welch DR.

Mol Carcinog. 2014 Dec;53(12):1011-26. doi: 10.1002/mc.22068. Epub 2013 Sep 2.


Mitochondrial genetic background modulates bioenergetics and susceptibility to acute cardiac volume overload.

Fetterman JL, Zelickson BR, Johnson LW, Moellering DR, Westbrook DG, Pompilius M, Sammy MJ, Johnson M, Dunham-Snary KJ, Cao X, Bradley WE, Zhang J, Wei CC, Chacko B, Schurr TG, Kesterson RA, Dell'italia LJ, Darley-Usmar VM, Welch DR, Ballinger SW.

Biochem J. 2013 Oct 15;455(2):157-67. doi: 10.1042/BJ20130029. Erratum in: Biochem J. 2013 Oct 1;455(1):147.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk